I am qualified in medicine in Burkina and worked as a clinician before entering methodological research. I completed in 2014 a Master of public heath (oriented in quantitative methods) and in 2018, a PhD in full-time in clinical research and public heath, both at Aix Marseille University, France. My PhD thesis topic was the extension of excess mortality analysis in to the field of clinical research. Previously, I worked in the SESSTIM research unit, as a biostatistician, mainly working on excess hazard and net survival methods in the field of clinical trials. I joined the Bourguignon Digestive Cancer Registry ( EPICAD team - UMR 1231) in January 2020 as a postdoctoral research fellow. Here is a link to my updated list of publications: Updated Publications LIST.
PhD in Clinical research and public Health (option biostatistics), 2018
Aix Marseille University
Master of Public Health (quantitative and econometric methods in health research), 2014
Aix Marseille University
Doctor of Medicine, 2012
Université de Ouagadougou
Responsibilities include:
Developing adaptative statistical learning platform for statistical learning
Responsibilities include:
using Rpubs to present differences betwenn chisq.test() and prop.test() R functions via external_link
.
See talks page.
In conclusion, the new RBS model allows estimating net survival in clinical trials. It corrects the biases of cause-of-death misclassification and of selection effect on the expected mortality in the general population. This makes it particularly useful in clinical trials with long follow-ups. With the RBS model, the researcher obtains accurate estimates of the excess hazard and, therefore, of net survival; however, he/she should check the strong assumption of homogeneous selection. Finally, the RBS model paves the way for new methodological developments in the field of net survival methods in multicenter clinical trials.